Növelte a Waberer’sben meglévő részesedését a BDPST Group, miután csoport tulajdonában lévő Geraldton Invest újabb részvénycsomagot vásárolt - derült ki a cég közleményéből. A bejelentés alapján a ...

“Together with our partners at Valo Health and through our ongoing collaboration with Flagship’s Pioneering Medicines, we look forward to further leveraging the power of Logica to advance this ...

Az árrésstop bevezetése óta számos - jellemzően nem az érintett körbe tartozó - élelmiszer ára jelentősen változott, de nem mindig az elvárt irányba. Miközben a hatósági árazás elvileg a vásárlók ...

CAMBRIDGE, Mass. & LEXINGTON, Mass., March 18, 2025--(BUSINESS WIRE)--Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...

Valo Therapeutics Oy announces that it has successfully secured a financing round of €19 million, part of which was raised in Europe and part in Australia, to clinically develop its innovative immune ...

Sony Music Publishing Germany has signed a worldwide publishing deal with songwriter and artist Ville Valo. The agreement encompasses both HIM’s back catalogue and Valo’s future works.

The BJP has launched its fourth campaign song, 'Dil valo ki Delhi ko ab BJP Sarkar chahiye', for the upcoming Delhi Assembly elections. BJP leaders praised the Union Budget as a 'golden budget'.

Novo Nordisk NOVO.B-2.26%decrease; red down pointing triangle expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Bagsværd, Denmark and Lexington, Massachusetts, US, 8 January 2025 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...

Novo Nordisk’s collaboration with artificial intelligence startup Valo Health has focused on developing new drugs for cardiovascular disease. The pharmaceutical giant likes what it’s seen so ...

Novo Nordisk expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and artificial intelligence. The deal ...

Under the expanded partnership, Novo Nordisk has agreed to pay Valo $190 million upfront, up-to-$4.6 billion in milestones, plus R&D funding and potential royalty payments. “This level of ...